NEUROBLASTOMA, SUSCEPTIBILITY TO, 3
|
disease |
|
Finding
|
1
|
16
|
0.600 |
definitive |
1.000 |
8 |
16
|
2008 |
2012 |
Leiomyoma of small intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Anaplastic large cell lymphoma T- and null-cell types refractory
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Myxoid leiomyoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
|
0.010 |
None |
< 0.001 |
1 |
|
2017 |
2017 |
Tumor lysis syndrome (spontaneous)
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Anaplastic Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Subclavicular lymphadenopathy
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Granuloma, Plasma Cell
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
2
|
|
0.300 |
None |
1.000 |
3 |
|
2010 |
2012 |
Plasma Cell Granuloma, Pulmonary
|
disease |
Respiratory Tract Diseases
|
Neoplastic Process
|
2
|
|
0.310 |
None |
1.000 |
2 |
|
2001 |
2011 |
Compound nevus of skin
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Disorder of pericardium
|
disease |
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Deep Penetrating Nevus
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Inflammatory pseudotumor of liver
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Pleural Carcinomatosis
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Subglottic hemangioma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Severe cutaneous adverse reactions (SMQ)
|
phenotype |
|
Classification
|
2
|
2
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Mucinous (colloid) adenocarcinoma
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Congenital neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2
|
2
|
0.010 |
None |
1.000 |
1 |
2
|
2014 |
2014 |
Medulloblastoma, WNT-Activated
|
disease |
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Metastatic Lung Non-Small Cell Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Secondary malignant neoplasm of spinal cord
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2018 |
Urinary Bladder Inflammatory Myofibroblastic Tumor
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
3
|
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2017 |
Prostate Stromal Proliferation of Uncertain Malignant Potential
|
disease |
|
Neoplastic Process
|
3
|
|
0.020 |
None |
0.500 |
2 |
|
2015 |
2019 |
Chromosome 2, trisomy 2p
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Gastric Inflammatory Myofibroblastic Tumor
|
disease |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |